Molecular Biology Reagents Market by Application, End-User (Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospitals & Diagnostic Centers, and other end users), and region (North America, Europe, Asia-Pacific, Middle East, Africa, and South America).
The Molecular Biology Reagents Market size is expected to reach USD 10.2 billion and is projected to reach a CAGR of 14.3% from 2023-2030.
Reagents are essential to the success of PCR reactions, nucleic acid separation, and restriction enzyme digestion experiments. Working with appropriate and dependable materials like buffers, water, enzymes, and chemicals is essential since molecular biology reagents may make or break your experiment or sample preparation.
Water that is suitable for amplification processes and processing RNA includes PCR-Grade and RNase-Free water, respectively. DNA and nucleotides can be purchased alone or as a component of genomic and protein packages. We provide chelating agents EDTA and EGTA, which are often used and designed for a variety of DNA, protein, and cell culture tasks. We provide a wide range of enzymes for genomic research, including but not restricted to polymerases, topoisomerases, and methylases.
The Molecular Biology Reagents market size has grown significantly in recent years. However, due to the outbreak of the COVID-19 pandemic, the market experienced a sharp decline in 2020. Governments from all around the world are collaborating with pharmaceutical and biotech businesses to combat the COVID-19 epidemic, from fostering the creation of vaccinations to preparing for issues with the distribution of medical supplies. The market for molecular biology enzymes, kits, and reagents is also anticipated to be significantly impacted by COVID-19 due to the disruption of the raw material supply chain in several nations. In addition, as makers of these items have slowed down their manufacturing as a result of the pandemic, the market growth of molecular biology reagents is dropping.
The study of genomics and molecular biology has undergone a complete transformation thanks to the ever-expanding uses of sequencing technologies and the creation of enormous data sets. NGS's introduction made it possible to sequence DNA in a quick and inexpensive manner. Together with NGS, third-generation sequencing technology is revitalizing genome sequencing and solving long-standing issues with de novo genome assembly, haplotype phasing, and structural variation analysis. Companies are continually developing and releasing new sequencing reagents in response to the increased demand for sequencing technologies on a worldwide scale which is further anticipating the growth of the molecular biology reagent market.
North America to Dominate the Market